Bulk Price Global Manufacturer (2R,3S)-N-Boc-3-Phenylisoserine 2026
- Competitive FOB pricing structures available for multi-kilogram strategic orders.
- Verified industrial purity exceeding 99% with full COA documentation provided.
- Reliable monthly supply capacity ensuring uninterrupted production cycles for clients.
The pharmaceutical intermediate landscape is evolving rapidly, demanding higher standards for chiral building blocks used in complex drug synthesis. Among these, (2R,3S)-N-Boc-3-Phenylisoserine (CAS: 145514-62-1) stands out as a critical precursor for taxane-based chemotherapeutics and advanced peptide formulations. As we approach 2026, procurement strategies must shift from simple transactional buying to partnerships with established entities that guarantee consistency, regulatory compliance, and technical support. This analysis details the commercial and technical parameters required for sourcing this high-value compound effectively.
For pharmaceutical developers and contract manufacturing organizations, securing a reliable source of (2R,3S)-Boc-3-Phenylisoserine is not merely about cost; it is about risk mitigation. Variability in optical purity or residual solvent content can derail downstream synthesis, leading to significant financial losses. Therefore, engaging with a dedicated global manufacturer who specializes in process chemistry is essential for maintaining supply chain integrity.
FOB Price and Minimum Order Quantity Analysis
Pricing dynamics for chiral intermediates are influenced by raw material availability, synthesis complexity, and order volume. In the current market, the bulk price for (2R,3S)-N-Boc-3-Phenylisoserine is structured to reward volume commitments. While spot prices for gram-scale samples remain higher due to packaging and quality control overheads, metric-ton contracts offer substantial reductions in cost per kilogram.
Minimum Order Quantity (MOQ) flexibility is a key differentiator among suppliers. Leading facilities often accommodate pilot plant requirements starting from 1 kg, scaling up to multi-ton deliveries for commercial production. The following table outlines typical specification tiers and their associated commercial implications:
| Specification Grade | Purity Standard | Typical MOQ | Lead Time |
|---|---|---|---|
| Research Grade | 98% min | 100 g - 1 kg | 3-5 Days |
| GMP Pilot Grade | 99% min | 1 kg - 10 kg | 7-14 Days |
| Commercial Bulk | 99.5% min | 25 kg+ | 15-30 Days |
It is important to note that FOB terms usually exclude customs duties and import taxes, which vary by region. Buyers should request detailed proforma invoices that break down freight costs separately from the product value to accurately assess landed costs. Furthermore, price stability clauses are often negotiable for long-term contracts, protecting buyers from raw material volatility in the upstream supply chain.
Global Supply Chain and Origin Verification
Verifying the origin and quality documentation of chemical intermediates is a regulatory necessity. A robust manufacturing process ensures that every batch meets stringent safety and efficacy standards. When auditing a potential supplier, procurement teams should request a comprehensive suite of documents, including Safety Data Sheets (SDS), Product Specifications (PS), and Certificates of Analysis (COA).
The COA is particularly critical, as it confirms the specific batch properties against the claimed specifications. Key parameters to verify on the COA include:
- Chemical Purity: Determined via HPLC, ensuring the main peak area matches the standard.
- Optical Rotation: Confirms the correct stereochemistry ((2R,3S) configuration), which is vital for biological activity.
- Residual Solvents: Must comply with ICH Q3C guidelines to ensure safety for pharmaceutical use.
- Heavy Metals: Verification that levels are within acceptable limits for human consumption applications.
Origin verification also extends to the raw materials used in the synthesis. Transparent suppliers provide Certificates of Origin (COO) to confirm the geographic source of production, which is essential for customs clearance and trade compliance. NINGBO INNO PHARMCHEM CO.,LTD. maintains rigorous documentation standards, ensuring that all exports are accompanied by valid regulatory paperwork to facilitate smooth customs processing worldwide.
2026 Market Trends for Bulk Procurement
Looking toward 2026, the demand for Taxane Intermediate precursors is projected to rise alongside the global increase in oncology drug development. (2R,3S)-N-Boc-3-Phenylisoserine is a key side-chain component for paclitaxel and docetaxel synthesis. As patent cliffs approach for certain biologics, the shift toward complex small-molecule generics will drive volume requirements for high-quality chiral intermediates.
Process efficiency will become a dominant factor in supplier selection. Manufacturers who have optimized their synthesis route to improve yields and reduce waste will offer more competitive pricing and better environmental compliance. When evaluating partners for large-volume production, assessing their scale-up capability is critical to ensuring that pilot success translates to commercial viability without quality degradation.
Additionally, the trend toward industrial purity standards exceeding 99% is becoming the norm rather than the exception. Downstream processors require materials that minimize purification steps, thereby reducing overall production costs and time-to-market. Suppliers capable of delivering this level of consistency consistently will dominate the supply landscape.
Technical Properties and Storage
Proper handling and storage are essential to maintain the integrity of Boc-protected amino acids. Exposure to moisture or elevated temperatures can lead to deprotection or racemization. The following technical data summarizes the physical properties relevant to logistics and storage planning:
| Property | Value |
|---|---|
| Molecular Formula | C14H19NO5 |
| Molecular Weight | 281.30 g/mol |
| Storage Condition | -15°C to -20°C (Freezer) |
| Appearance | White to Off-White Crystalline Powder |
| Boiling Point | 470.4°C at 760 mmHg |
Investing in proper cold chain logistics is non-negotiable for preserving the shelf life of this compound. Buyers should ensure that their receiving facilities are equipped to store materials at the recommended temperatures immediately upon arrival.
Conclusion
The procurement of (2R,3S)-N-Boc-3-Phenylisoserine for 2026 and beyond requires a strategic approach focused on quality, capacity, and compliance. By prioritizing suppliers with proven manufacturing process excellence and transparent documentation, pharmaceutical companies can secure their supply chains against market volatility. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to delivering high-purity intermediates that meet the rigorous demands of modern drug development, ensuring that partners have the materials they need to bring life-saving therapies to market efficiently.